Foley & Lardner LLP
Method and compositions for inhibiting cell proliferative disorders
The present invention concerns compounds and their use to inhibit the activity of a receptor tyrosine kinase. The invention is preferably used to treat cell proliferative disorders such as cancers characterized by over-activity or inappropriate activity HER2 or EGFR.
Sugen, Inc. Yissum Research and Development Company of the Hebrew University of Jerusalem
C A A C C C C C A C A C A A C C A
C07D A61K A61K C07C C07C C07C C07C C07C A61K C07C A61K C07C A61K A61K C07C C07C A61K
inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional
Aviv Peng Cho Jianming Klaus Peter Alexander Laura K. Hui Elaina
Gazit Tang Tsai Hirth Levitzki Shawver Chen Mann